ConductScience.org, home

Paper10896236

Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group.

Goodeve AC and 3 others. Thromb Haemost, 2000. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group. Papers, record 10896236. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10896236

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group.
PubMed
Journal
Thromb Haemost
PubMed
Year
2000
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
1.18
iCite
Revised in PubMed
2009-11-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goodeve ACA C
2Williams II
3Bray GLG L
4Peake IRI R

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AutoantibodiesMajor topic
Factor VIIIMajor topic
Hemophilia AMajor topic
MutationMajor topic
Antibody Formation
Chromosome Inversion
Cohort Studies
DNA Mutational Analysis
Drug Evaluation
Frameshift Mutation
Gene Deletion
Humans
Mutation, Missense
Point Mutation
Recombinant Proteins

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
40879869Missense and nonsense mutations and inhibitor development in patients with hemophilia A and B.J Thromb Thrombolysis2026https://conductscience.org/library/papers/40879869PubMed
39125936Mutational Profile in Romanian Patients with Hemophilia A.Int J Mol Sci2024https://conductscience.org/library/papers/39125936PubMed
22423892In silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B.J Biomed Sci2012https://conductscience.org/library/papers/22423892PubMed
20533009Mutation analysis of factor VIII in Korean patients with severe hemophilia A.Int J Hematol2010https://conductscience.org/library/papers/20533009PubMed
19330068Detection of FLT3 oncogene mutations in acute myeloid leukemia using conformation sensitive gel electrophoresis.Int J Mol Sci2008https://conductscience.org/library/papers/19330068PubMed
19199081Factor VIII inhibitors: risk factors and methods for prevention and immune modulation.Clin Rev Allergy Immunol2009https://conductscience.org/library/papers/19199081PubMed
19160072Varied immune response to FVIII: presence of proteolytic antibodies directed to factor VIII in different human pathologies.Clin Rev Allergy Immunol2009https://conductscience.org/library/papers/19160072PubMed
18688246Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment.Nat Biotechnol2008https://conductscience.org/library/papers/18688246PubMed
15168603Inversions of the factor VIII gene in Japanese patients with severe hemophilia A.Int J Hematol2004https://conductscience.org/library/papers/15168603PubMed
11950963Haemophilia A and haemophilia B: molecular insights.Mol Pathol2002https://conductscience.org/library/papers/11950963PubMed
11836440Haemophilia A and haemophilia B: molecular insights.Mol Pathol2002https://conductscience.org/library/papers/11836440PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
F82157Swiss-Prot's referenceshttps://conductscience.org/library/genes/2157

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10896236

GET https://conductscience.org/api/papers/v1/10896236/authors